BMS to move 100 jobs from Syracuse; India nixes Gilead, Roche patent apps;

> Bristol-Myers Squibb says it will cut 100 jobs from its Syracuse-area operations by the end of 2010 as the drug maker consolidates its Drug Safety Evaluation group into facilities in Indiana and New Jersey. Report

> Indian officials have rejected patent applications for Gilead Sciences' Hespera and for Roche's Tarceva salts form, saying they're not novel and so don't qualify for exclusivity. Report

> Cephalon is updating the prescribing information for its cancer treatment drug Treanda to include a warning about the use of the drug with allopurinol, according to documents filed with the SEC. Report

> The United States is putting Finland on a special observation list over Finland's system of reference prices for pharmaceuticals. Report

> The UK branded pharmaceutical market looks set to decline from 2009 onwards as the volume of drugs remains flat but prices are cut, predicts a recent report by market analyst Datamonitor. Report

> The FDA has authorized the emergency use of antivirals and diagnostic tests to help fight the spread of swine flu in the United States. Report

> President Barack Obama asked Congress for $1.5 billion today to fight a new version of swine flu that is spreading in the U.S. and around the world. California Governor Arnold Schwarzenegger, meanwhile, declared a state of emergency after health officials began to probe the deaths of two people who may have been infected with swine flu. Report

> Switzerland's Novartis has received the genetic code for the new swine flu virus that is raising alarms around the globe. And it hopes to get a sample of the actual virus soon as it begins work on a new vaccine that will guard against the disease. Report

> Corey Goodman had been Pfizer's go-to guy for biotechnology. But now he's out. Report

> San Diego-based Ardea Biosciences is pocketing a $35 million upfront payment and stands to earn another $372 million in milestones from a cancer drug development pact that it struck with Bayer HealthCare. Report

And Finally... As expected, Kathleen Sebelius was confirmed as HHS chief and sworn in last evening; now she confronts the job of overseeing the government's efforts on swine flu. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.